CYP24A1 and neoplasm: This trial did not demonstrate decreased tumor growth compared to control groups treated with chemotherapy; however, an association between disease progression and some SNPs of the regulator of the vitamin D degradation enzyme coded by CYP24A1 gene was reported, suggesting that patient stratification based on selected CYP24A1 SNPs should be considered in future studies with vitamin D-related compounds [108].